gestational%20diabetes%20mellitus
GESTATIONAL DIABETES MELLITUS
Gestational diabetes mellitus (GDM) is any degree of glucose intolerance with onset or first recognition during pregnancy.
Hyperglycemia in pregnancy may be suggested by the presence of glycosuria, a fetus that is large for date, or polyhydramnios.
Overt diabetes mellitus may be found in women presenting with risk factors for type 2 diabetes during the first prenatal visit (before 13 weeks of gestation).

Introduction

Gestational Diabetes Mellitus (GDM)
  • Any degree of glucose intolerance with onset or first recognition during pregnancy 
    • It is diabetes that is first diagnosed in the 2nd or 3rd trimester of pregnancy that has not been a pre-existing type 1 or 2 diabetes  
  • Hyperglycemia in pregnancy may be suggested by the presence of glycosuria, a fetus that is large for date, or polyhydramnios  
  • Prevalence of GDM appears to be high in South Asia and South East Asian women compared to African-American, Caucasian and Hispanic women; prevalence rates are 3-21.2% in women with GDM who were born in Asian countries  
    • Rates of fetal macrosomia are lower in South East Asian women than in American Caucasian women  
    • Asian women with GDM have a higher incidence of abnormal postpartum glucose tolerance tests and risk of developing type 2 DM in the future is higher than in Anglo-European women
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
4 days ago
Early screening for gestational diabetes does not improve the composite perinatal outcomes in obese women, reveals a study.
Audrey Abella, 4 days ago
A novel, investigational vaginal pH regulator (VPR) – a nonhormonal, water-based, petroleum-free contraceptive vaginal gel – improved genitourinary (GU) side effects and sexual satisfaction in women who are at risk of pregnancy but are not aiming to conceive, interim findings from the phase III AMPOWER* trial show.
Pearl Toh, 21 May 2020
A levonorgestrel (LNG)-releasing intrauterine device (IUD) maintains high contraceptive efficacy up to 6 years, which is beyond the 5-year period it is currently approved for, according to data from the Mirena Extension Trial (MET) released during the ACOG 2020 Meeting.
12 Dec 2019
Rotavirus (RV) is highly contagious. Globally, 2 million children are hospitalized and more than 500,000 die annually from RV associated gastroenteritis. Therefore, vaccination is imperative for the prevention of RV infections.